| Jalilehvand, Farideh; Enriquez Garcia, Alejandra; Niksirat, Pantea; Finfrock, Y. Zou; Gelfand, Benjamin S. et al. (2021). Binding of histidine and human serum albumin to dirhodium(II) tetraacetate. Journal of Inorganic Biochemistry 224, 111556. 10.1016/j.jinorgbio.2021.111556. |
CLS-APS |
Peer-Reviewed Article |
Agriculture |
| Jalilehvand, Farideh; Homayonia, Saba; Zhang, Ping; Ling, Chang-Chun (2023). Gadolinium(III) complex formation with a β-cyclodextrin ligand: an XAS study of a potential MRI contrast agent. Journal of Biological Inorganic Chemistry . 10.1007/s00775-023-02027-9. |
BIOXAS-MAIN, BIOXAS-SPECTROSCOPY |
Peer-Reviewed Article |
Health |
| James, Ashley (2021). Accumulation, distribution and chemical form of organic mercury in brain tissue and larval zebrafish (Danio rerio). University of Saskatchewan. https://harvest.usask.ca/server/api/core/bitstreams/0c9084c9-2670-4c5f-957e-3891cdd93666/content. |
CLS-APS |
Doctoral Thesis |
Agriculture |
| James, Ashley K.; Dolgova, Natalia V.; Nehzati, Susan; Korbas, Malgorzata; Cotelesage, Julien J. H. et al. (2022). Molecular Fates of Organometallic Mercury in Human Brain. ACS Chemical Neuroscience 13(12) , 1756-1768. 10.1021/acschemneuro.2c00166. |
CLS-APS |
Peer-Reviewed Article |
Health |
| James Bryson; Philip DREW; Steven Grant; Stanley Krystek; Steven Sheriff et al. (2017). Antibody polypeptides that antagonize cd40. Patent Number: AU2016202672B2. |
CMCF-ID |
Patent |
Health |
| James Bryson; Philip DREW; Steven Grant; Stanley Krystek; Steven Sheriff et al. (2016). Antibody polypeptides that antagonize CD40. Patent Number: AU2012245309C1. |
|
Patent |
|
| James Philip O'connell; John Robert Porter; Alastair Lawson; Boris Kroeplien; Stephen Edward Rapecki et al. (2021). Mechanism of action. Patent Number: ES2836769T3. |
|
Patent |
|
| James Philip O'CONNELL; John Robert Porter; Alastair Lawson; Boris Kroeplien; Stephen Edward Rapecki et al. (2025). Mechanism of action. Patent Number: US20250012807A1. |
|
Patent |
|
| James Philip O'CONNELL; John Robert Porter; Alastair Lawson; Boris Kroeplien; Stephen Edward Rapecki et al. (2021). Mechanism of action. Patent Number: US20210140972A1. |
|
Patent |
|
| James Philip O'CONNELL; John Robert Porter; Alastair Lawson; Boris Kroeplien; Stephen Edward Rapecki et al. (2021). Methods of identifying signaling modulators of the trimeric TNFa. Patent Number: US10883996B2. |
|
Patent |
|
| James Philip O'CONNELL; John Robert Porter; Alastair Lawson; Boris KROEPLIEN; Stephen Edward Rapecki et al. (2020). Modulation of members of the tnf-superfamily. Patent Number: EP3311167B1. |
|
Patent |
|
| James Philip O'CONNELL; John Robert Porter; Alastair Lawson; Boris KROEPLIEN; Stephen Edward Rapecki et al. (2016). Mechanism of action. Patent Number: WO2016202411A1. |
|
Patent |
|
| James Philip O'CONNELL; John Robert Porter; Alastair Lawson; Boris KROEPLIEN; Stephen Edward Rapecki et al. (2023). Modulation of members of the tnf superfamily. Patent Number: CA2987823C. |
|
Patent |
|
| James Philip O'connell; John Robert Porter; Alastair Lawson; Boris Kroeplien; Stephen Edward Rapecki et al. (2022). Modulator Assay. Patent Number: ES2895486T3. |
|
Patent |
|
| James Philip O′Connell; John Robert Porter; Alastair Lawson; Boris Kroeplien; Stephen Edward Rapecki et al. (2025). Complexes between CD40 and compounds comprising benzimidazole moieties. Patent Number: US12474348B2. |
|
Patent |
|